对美特福林配方的市场形式和分析方法的全面分析
Saravana Muthu Kumar Pandian1, Punniyakoti V Thanikachalam2, Deviga Kaliyappan3
1Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India.
Biomedical chromatography : BMC
|March 12, 2025
概括
甲胺是2型糖尿病的关键治疗方法,可提供先进的配方. 分析方法确保了这些新型甲胺药物输送系统的安全性和有效性.
科学领域:
- 制药科学 制药科学
- 分析化学 分析化学
- 内分泌学 在内分泌学.
背景情况:
- 甲福明是一种口服抗高血糖药,已是50多年来2型糖尿病 (T2DM) 的首要治疗方法.
- 它在全球范围内被广泛用于管理非胰岛素依赖性糖尿病和其他疾病.
- 最近的研究重点是通过先进的配方来提高甲福明的有效性,耐受性和非血糖益处.
研究的目的:
- 批判性地审查用于评估甲福明配方的分析方法.
- 为了突出梅特福林药物输送系统的进步.
- 为未来开发和评估甲福明配方提供洞察力.
主要方法:
- 在科学数据库中进行全面的文献搜索.
- 对色谱和光谱分析技术的评估.
- 对各种甲胺化物 (HCl) 配方的审查,包括水凝,固体剂型和局部制剂.
主要成果:
- 各种甲HCl配方提供了诸如持续释放,改善生物可用性和伤口愈合潜力等好处.
- 像RP-HPLC和UV可见光谱等分析方法对于确保配方安全性,稳定性和准确量化至关重要.
- 这些进展支持个性化T2DM治疗,改善血糖控制和患者的治疗结果.
结论:
- 先进的甲福林配方和强大的分析方法对于优化T2DM管理至关重要.
- 这些进展有助于提高治疗效率和糖尿病护理患者的治疗结果.
- 该审查为研究人员和制药专家提供了宝贵的见解,用于开发甲福林配方.
相关概念视频
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
276
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
276
Oral Hypoglycemic Agents: Biguanides and Glitazones
148
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
148
Insulin Formulations: Types and Delivery
150
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
150
Factors Influencing Drug Absorption: Pharmaceutical Parameters
111
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
111
Analysis of Population Pharmacokinetic Data
208
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
208
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
77
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
77


